Airdate: Tuesday, September 26, 2023 Season: 10 Episode: 21
Guest: Víctor Andrés Arrieta
Dr. Víctor Andrés Arrieta from the Department of Neurosurgery at Northwestern University Feinberg School of Medicine answers questions from a recent webinar discussing the relationship between p-ERK activation and enhanced survival outcomes in rGBM patients undergoing anti-PD-1 immunotherapy.
Associated Webinar: Exploring Predictive Biomarkers and ERK1/2 Phosphorylation: A New Horizon in Forecasting Survival and Response to Immune Checkpoint Blockade in Glioblastoma Treatment
Similar Podcasts
#ExpertAnswers: Catherine Ewen on Setting Up DC and CD8⁺ T Cell Co-culture Experiments
Dr. Catherine Ewen from STEMCELL Technologies answers questions from a recent webinar where she describes how to set up DC and CD8⁺ T cell co-culture experiments and assess T cell proliferation and activity.
#ExpertAnswers: Lorcan Sherry and Aditya Pratapa on Analyzing Multiplex Immunofluorescence Images
Dr. Lorcan Sherry and Dr. Aditya Pratapa answer questions from a recent webinar where they present a novel workflow for analyzing multiplex immunofluorescence images.
#ExpertAnswers: Conor McCartin on Phage Display Technologies
Dr. Conor McCartin from ProteoGenix answers questions about the utilization of phage display in the development of human antibodies.